TCR/CD28-stimulated actin dynamics are required for NFAT1-mediated transcription of c-rel leading to CD28 response element activation

Journal of Immunology

Volumn 179, Issue 2, 2007, Pages 1104-1112

  Nolz, Jeffrey C ^a   Fernandez Zapico, Martin E ^b   Billadeau, Daniel D ^a,c  

^a MAYO GRADUATE SCHOOL   (United States)

^b MAYO CLINIC   (United States)

^c Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD4 ANTIGEN; CYTOCHALASIN; CYTOCHALASIN D; INTERLEUKIN 2; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR REL; ACTIN; CALCIUM; CYTOCHALASIN C; LYMPHOCYTE ANTIGEN RECEPTOR; NFATC2 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GENE; CALCIUM TRANSPORT; CD4+ T LYMPHOCYTE; CELL STIMULATION; CYTOSKELETON; DNA RESPONSIVE ELEMENT; GENETIC TRANSCRIPTION; HUMAN; PRIORITY JOURNAL; PROMOTER REGION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STIMULATION; T LYMPHOCYTE ACTIVATION; UPREGULATION; DRUG EFFECT; GENETICS; IMMUNOLOGY; LEUKEMIA CELL LINE; LYMPHOCYTE ACTIVATION; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; WESTERN BLOTTING;

ACTINS; ANTIGENS, CD28; BASE SEQUENCE; BLOTTING, WESTERN; CALCIUM; CYTOCHALASINS; CYTOSKELETON; HUMANS; INTERLEUKIN-2; JURKAT CELLS; LYMPHOCYTE ACTIVATION; MOLECULAR SEQUENCE DATA; NFATC TRANSCRIPTION FACTORS; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-REL; RECEPTORS, ANTIGEN, T-CELL; RESPONSE ELEMENTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TRANSCRIPTION, GENETIC;

EID: 34548738373     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.179.2.1104     Document Type: Article

References (50)

1. Iezzi, G., K. Karjalainen, and A. Lanzavecchia. 1998. The duration of antigenic stimulation determines the fate of naive and effector T cells. Immunity 8: 89-95.
2. Tskvitaria-Fuller, I., A. L. Rozelle, H. L. Yin, and C. Wülfing. 2003. Regulation of sustained actin dynamics by the TCR and costimulation as a mechanism of receptor localization. J. Immunol. 171: 2287-2295.
3. Valitutti, S., M. Dessing, K. Aktories, H. Gallati, and A. Lanzavecchia. 1995. Sustained signaling leading to T cell activation results from prolonged T cell receptor occupancy: role of T cell actin cytoskeleton. J. Exp. Med. 181: 577-584.
4. Campi, G., R. Varma, and M. L. Dustin. 2005. Actin and agonist MHC-peptide complex-dependent T cell receptor microclusters as scaffolds for signaling. J. Exp. Med. 202: 1031-1036.
5. Billadeau, D. D., J. C. Nolz, and T. S. Gomez. 2007. Regulation of T-cell activation by the cytoskeleton. Nat. Rev. Immunol. 7: 131-143.
6. Jain, J., C. Loh, and A. Rao. 1995. Transcriptional regulation of the IL-2 gene. Curr. Opin. Immunol. 7: 333-342.
7. Lucas, P. C., L. M. McAllister-Lucas, and G. Nunez. 2004. NF-κB signaling in lymphocytes: a new cast of characters. J. Cell Sci. 117: 31-39.
8. Wang, D., R. Matsumoto, Y. You, T. Che, X. Y. Lin, S. L. Gaffen, and X. Lin. 2004. CD3/CD28 costimulation-induced NF-κB activation is mediated by recruitment of protein kinase C-θ-, Bcl10, and IκB kinase β to the immunological synapse through CARMA1. Mol. Cell Biol. 24: 164-171.
9. ras upon T-cell activation. Nature 346: 719-723.
10. Rincon, M. 2001. MAP-kinase signaling pathways in T cells. Curr. Opin. Immunol. 13: 339-345.
11. 2+/calcineurin signalling in cells of the immune system. Biochem. Biophys. Res. Commun. 311: 1117-1132.
12. Fraser, J. D., B. A. Irving, G. R. Crabtree, and A. Weiss. 1991. Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. Science 251: 313-316.
13. Shapiro, V. S., K. E. Truitt, J. B. Imboden, and A. Weiss. 1997. CD28 mediates transcriptional upregulation of the interleukin-2 (IL-2) promoter through a composite element containing the CD28RE and NF-IL-2B AP-1 sites. Mol. Cell Biol. 17: 4051-4058.
14. Shapiro, V. S., M. N. Mollenauer, W. C. Greene, and A. Weiss. 1996. c-Rel regulation of IL-2 gene expression may be mediated through activation of AP-1. J. Exp. Med. 184: 1663-1669.
15. Huang, D. B., Y. Q. Chen, M. Ruetsche, C. B. Phelps, and G. Ghosh. 2001. X-ray crystal structure of proto-oncogene product c-Rel bound to the CD28 response element of IL-2. Structure 9: 669-678.
16. Butscher, W. G., C. Powers, M. Olive, C. Vinson, and K. Gardner. 1998. Coordinate transactivation of the interleukin-2 CD28 response element by c-Rel and ATF-1/CREB2. J. Biol. Chem. 273: 552-560.
17. Nolz, J. C., T. S. Gomez, P. Zhu, S. Li, R. B. Medeiros, Y. Shimizu, J. K. Burkhardt, B. D. Freedman, and D. D. Billadeau. 2006. The WAVE2 complex regulates actin cytoskeletal reorganization and CRAC-mediated calcium entry during T cell activation. Curr. Biol. 16: 24-34.
18. Gomez, T. S., M. J. Hamann, S. McCarney, D. N. Savoy, C. M. Lubking, M. P. Heldebrant, C. M. Labno, D. J. McKean, M. A. McNiven, J. K. Burkhardt, and D. D. Billadeau. 2005. Dynamin 2 regulates T cell activation by controlling actin polymerization at the immunological synapse. Nat. Immunol. 6: 261-270.
19. Billadeau, D. D., S. M. Mackie, R. A. Schoon, and P. J. Leibson. 2000. Specific subdomains of Vav differentially affect T cell and NK cell activation. J. Immunol. 164: 3971-3981.
20. Cao, Y., E. M. Janssen, A. W. Duncan, A. Altman, D. D. Billadeau, and R. T. Abraham. 2002. Pleiotropic defects in TCR signaling in a Vav-1-null Jurkat T-cell line. EMBO J. 21: 4809-4819.
21. Gomez, T. S., K. Kumar, R. B. Medeiros, Y. Shimizu, P. J. Leibson, and D. D. Billadeau. 2007. Formins regulate the actin-related protein 2/3 complex-independent polarization of the centrosome to the immunological synapse. Immunity 26: 177-190.
22. Trushin, S. A., K. N. Pennington, E. M. Carmona, S. Asin, D. N. Savoy, D. D. Billadeau, and C. V. Paya. 2003. Protein kinase Cα (PKCα) acts upstream of PKC-θ to activate IκB kinase and NF-κB in T lymphocytes. Mol. Cell Biol. 23: 7068-7081.
23. Morgan, M. M., C. M. Labno, G. A. Van Seventer, M. F. Denny, D. B. Straus, and J. K. Burkhardt. 2001. Superantigen-induced T cell:B cell conjugation is mediated by LFA-1 and requires signaling through Lck, but not ZAP-70. J. Immunol. 167: 5708-5718.
24. Billadeau, D. D., S. M. Mackie, R. A. Schoon, and P. J. Leibson. 2000. The Rho family guanine nucleotide exchange factor Vav-2 regulates the development of cell-mediated cytotoxicity. J. Exp. Med. 192: 381-392.
25. Ougolkov, A., B. Zhang, K. Yamashita, V. Bilim, M. Mai, S. Y. Fuchs, and T. Minamoto. 2004. Associations among β-TrCP, an E3 ubiquitin ligase receptor, β-catenin, and NF-κB in colorectal cancer. J. Natl. Cancer Inst. 96: 1161-1170.
26. Holsinger, L. J., I. A. Graef, W. Swat, T. Chi, D. M. Bautista, L. Davidson, R. S. Lewis, F. W. Alt, and G. R. Crabtree. 1998. Defects in actin-cap formation in Vav-deficient mice implicate an actin requirement for lymphocyte signal transduction. Curr. Biol. 8: 563-572.
27. Rivas, F. V., J. P. O'Keefe, M. L. Alegre, and T. F. Gajewski. 2004. Actin cytoskeleton regulates calcium dynamics and NFAT nuclear duration. Mol. Cell Biol. 24: 1628-1639.
28. Venkataraman, L., S. J. Burakoff, and R. Sen. 1995. FK506 inhibits antigen receptor-mediated induction of c-rel in B and T lymphoid cells. J. Exp. Med. 181: 1091-1099.
29. Venkataraman, L., W. Wang, and R. Sen. 1996. Differential regulation of c-Rel translocation in activated B and T cells. J. Immunol. 157: 1149-1155.
30. Zhou, X. Y., Y. Yashiro-Ohtani, M. Nakahira, W. R. Park, R. Abe, T. Hamaoka, M. Naramura, H. Gu, and H. Fujiwara. 2002. Molecular mechanisms underlying differential contribution of CD28 versus non-CD28 costimulatory molecules to IL-2 promoter activation. J. Immunol. 168: 3847-3854.
31. Chiao, P. J., S. Miyamoto, and I. M. Verma. 1994. Autoregulation of IκBα activity. Proc. Natl. Acad. Sci. USA 91: 28-32.
32. Brown, K., S. Park, T. Kanno, G. Franzoso, and U. Siebenlist. 1993. Mutual regulation of the transcriptional activator NF-κB and its inhibitor, IκB-α. Proc. Natl. Acad. Sci. USA 90: 2532-2536.
33. Viswanathan, M., M. Yu, L. Mendoza, and J. J. Yunis. 1996. Cloning and transcription factor-binding sites of the human c-rel proto-oncogene promoter. Gene 170: 271-276.
34. Grumont, R. J., I. B. Richardson, C. Gaff, and S. Gerondakis. 1993. rel/NF-κB nuclear complexes that bind kB sites in the murine c-rel promoter are required for constitutive c-rel transcription in B-cells. Cell Growth Differ. 4: 731-743.
35. Macian, F., F. Garcia-Cozar, S. H. Im, H. F. Horton, M. C. Byrne, and A. Rao. 2002. Transcriptional mechanisms underlying lymphocyte tolerance. Cell 109: 719-731.
36. Krawczyk, C., A. Oliveira-dos-Santos, T. Sasaki, E. Griffiths, P. S. Ohashi, S. Snapper, F. Alt, and J. M. Penninger. 2002. Vav1 controls integrin clustering and MHC/peptide-specific cell adhesion to antigen-presenting cells. Immunity 16: 331-343.
37. Dombroski, D., R. A. Houghtling, C. M. Labno, P. Precht, A. Takesono, N. J. Caplen, D. D. Billadeau, R. L. Wange, J. K. Burkhardt, and P. L. Schwartzberg. 2005. Kinase-independent functions for Itk in TCR-induced regulation of Vav and the actin cytoskeleton. J. Immunol. 174: 1385-1392.
38. Grasis, J. A., C. D. Browne, and C. D. Tsoukas. 2003. Inducible T cell tyrosine kinase regulates actin-dependent cytoskeletal events induced by the T cell antigen receptor. J. Immunol. 170: 3971-3976.
39. Thrasher, A. J. 2002. WASp in immune-system organization and function. Nat. Rev. Immunol. 2: 635-646.
40. Zipfel, P. A., S. C. Bunnell, D. S. Witherow, J. J. Gu, E. M. Chislock, C. Ring, and A. M. Pendergast. 2006. Role for the ABI/WAVE protein complex in T cell receptor-mediated proliferation and cytoskeletal remodeling. Curr. Biol. 16: 35-46.
41. Reynolds, L. F., L. A. Smyth, T. Norton, N. Freshney, J. Downward, D. Kioussis, and V. L. Tybulewicz. 2002. Vav1 transduces T cell receptor signals to the activation of phospholipase C-γ1 via phosphoinositide 3-kinase-dependent and -independent pathways. J. Exp. Med. 195: 1103-1114.
42. 2+ store to the plasma membrane. Nature 437: 902-905.
43. 2+ store depletion causes STIM1 to accumulate in ER regions closely associated with the plasma membrane. J. Cell Biol. 174: 803-813.
44. Prakriya, M., S. Feske, Y. Gwack, S. Srikanth, A. Rao, and P. G. Hogan. 2006. Orai1 is an essential pore subunit of the CRAC channel. Nature 443: 230-233.
45. Rosado, J. A., S. Jenner, and S. O. Sage. 2000. A role for the actin cytoskeleton in the initiation and maintenance of store-mediated calcium entry in human platelets: evidence for conformational coupling. J. Biol. Chem. 275: 7527-7533.
46. Holda, J. R., and L. A. Blatter. 1997. Capacitative calcium entry is inhibited in vascular endothelial cells by disruption of cytoskeletal microfilaments. FEBS Lett. 403: 191-196.
47. Kontgen, F., R. J. Grumont, A. Strasser, D. Metcalf, R. Li, D. Tarlinton, and S. Gerondakis. 1995. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev. 9: 1965-1977.
48. Grumont, R., P. Lock, M. Mollinari, F. M. Shannon, A. Moore, and S. Gerondakis. 2004. The mitogen-induced increase in T cell size involves PKC and NFAT activation of Rel/NF-κB-dependent c-myc expression. Immunity 21: 19-30.
49. Parra, E., T. Mustelin, M. Dohlsten, and D. Mercola. 2001. Identification of a CD28 response element in the CD40 ligand promoter. J. Immunol. 166: 2437-2443.
50. Diehn, M., A. A. Alizadeh, O. J. Rando, C. L. Liu, K. Stankunas, D. Botstein, G. R. Crabtree, and P. O. Brown. 2002. Genomic expression programs and the integration of the CD28 costimulatory signal in T cell activation. Proc. Natl. Acad. Sci. USA 99: 11796-11801.